<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Patients with <z:hpo ids='HP_0005550'>chronic lymphocytic leukemia</z:hpo> (CLL) are at a significantly increased risk of developing a second malignant <z:hpo ids='HP_0002664'>neoplasm</z:hpo> in the course of their disease </plain></SENT>
<SENT sid="1" pm="."><plain>The occurrence of large cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> [<z:e sem="disease" ids="C0349631" disease_type="Neoplastic Process" abbrv="">Richter's syndrome</z:e> (RS)] has been described in approximately 3-5% of CLL patients </plain></SENT>
<SENT sid="2" pm="."><plain>Other types of secondary lymphoid <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> are extremely rare </plain></SENT>
<SENT sid="3" pm="."><plain>Here we describe a patient, heavily pretreated, with long history of CLL who developed a secondary follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, transformed into a diffuse large cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (LCL), with isolated manifestation in the bone, a very rare manifestation of RS </plain></SENT>
<SENT sid="4" pm="."><plain>CLL and LCL cells were of distinct clonal origin, as documented by DNA sequencing of the CDR3 regions </plain></SENT>
<SENT sid="5" pm="."><plain>Twelve months after the completion of chemo- and local radiotherapy, the patient is still in remission </plain></SENT>
</text></document>